Identification of Rab27a as a host factor for oncolytic herpes virus susceptibility to tumor cells.

Oncolytic viruses are emerging as therapeutic agents in oncology. However, resistance of tumor cells to HSV oncolysis pose significant barriers to antitumor response. Thus, study on the mechanisms of therapeutic resistance to oHSV and finding strategies for overcoming these mechanisms are needed. In this study, Rab27a, a small GTPase involved in exosome biogenesis, was noticed to highly correlate with the susceptibility of tumor cells to oHSV. We found that i) lower abundance of Rab27a in oHSV resistant mouse tumor cells was shown when compared to that of sensitive tumor cells through deep-sequencing; ii) the resistance of human tumor cells to oHSV infection is associated with a downregulation of Rab27a expression and overexpression of Rab27a can promote the replication capacity of oHSV; iii) Interestingly, a stabilizer protein of Rab27a, KIBRA, highly accumulated in oHSV resistant tumor cells, which is in contrast with the expression pattern of Rab27a. Furthermore, knockdown of KIBRA expression reduced oHSV replication in oHSV resistant tumor cells. Consequently, Rab27a was found to be relevant with oHSV replication without cell type specificity, and low abundance of Rab27a contributes to oHSV resistance in both mouse and human tumor cells, which will give new insights in the identification of potential targets or biomarkers for oHSV cancer therapy. Copyright © 2021 Elsevier B.V. All rights reserved.

Citation

XuSha Zhou, Jing Zhao, Yinglin Wu, Lei Wang, Dongmei Ji, Xiaoqing Chen, Peigen Ren, Grace Guoying Zhou. Identification of Rab27a as a host factor for oncolytic herpes virus susceptibility to tumor cells. Virus research. 2021 Jul 02;299:198425

Mesh Tags

Substances

PMID: 33905773

search → result